Back to Search

AUAYPORN NADEMANEE, MD

MD

Hematology & Oncology Physician

NPI: 1437160819Individual

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

A32859(CA)

Research & Publications (20)

Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.
PMID 17027658·Semin Hematol·2006
6-review
A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma.
PMID 16002426·Blood·2005
3-trial
Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.
PMID 11707813·Clin Lymphoma·2000
8-other
Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD.
PMID 19503110·Bone Marrow Transplant·2010
2-rct
Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization.
PMID 19483760·Bone Marrow Transplant·2010
3-trial
Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors.
PMID 19539214·Biol Blood Marrow Transplant·2009
3-trial
Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation.
PMID 19564171·Ann Oncol·2009
8-other
HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.
PMID 19224849·J Clin Oncol·2009
8-other
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.
PMID 19363221·Blood·2009
3-trial
Emergency double unrelated umbilical cord blood transplant for acute lymphoblastic leukemia after very late deferral of bone marrow donor.
PMID 18084336·Bone Marrow Transplant·2008
5-case
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438).
PMID 18256325·Blood·2008
3-trial
Hematopoietic stem cell transplantation for patients with advanced-stage follicular lymphoma.
PMID 18972908·J Med Assoc Thai·2008
8-other
Non-Hodgkin's lymphomas.
PMID 18433606·J Natl Compr Canc Netw·2008
6-review
Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.
PMID 18025438·J Clin Oncol·2008
3-trial
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma.
PMID 17448919·Biol Blood Marrow Transplant·2007
3-trial
Thymoma-associated severe aplastic anemia treated with surgical resection followed by allogeneic stem-cell transplantation.
PMID 17664486·J Clin Oncol·2007
5-case
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.
PMID 17671231·Blood·2007
8-other
Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
PMID 17714420·Transfusion·2007
8-other
Analysis of hematopoietic cell transplants using plasma-depleted cord blood products that are not red blood cell reduced.
PMID 17950921·Biol Blood Marrow Transplant·2007
4-observational
Use of radioimmunotherapy in stem cell transplantation and posttransplantation: focus on yttrium 90 ibritumomab tiuxetan.
PMID 18220907·Curr Stem Cell Res Ther·2007
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3229 STEVEN DR
ENCINO, CA 91436

Location

Practice Location

3229 STEVEN DR, ENCINO, CA
(818) 888-8888

Quick Facts

NPI
1437160819
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile